Drug Database
Back to search

Switzerland· 57365001

Santuril, Tabletten

A probenecid product containing probenecidum, registered in Switzerland by Lipomed AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC M04AB01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedSanturil, TablettenATCM04AB01REGISTER NO.57365001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about probenecidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Probenecid is registered in 9 of 19 countries.

Countries holding a registration under ATC M04AB01 (probenecid), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 5 of them publish a price we can compare per daily dose
Search probenecid products by name

Probenecid · ATC M04AB01

9 / 19 countries

  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of probenecid costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • Switzerland: $2.53 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Probenecid · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.53
  • FR France$1.71
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
probenecidum
Manufacturer
Lipomed AG
Country
Switzerland (CH)
ATC code
M04AB01
ATC class
Probenecid
Defined daily dose
1 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680573650012
    Blist 30 Stk
    CHF 38.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

86 interactions on record for probenecid.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check probenecid against other medicinesHow interaction checks work

Probenecid · interactions on record

86 records

  • 6 severe
  • 24 moderate
  • 11 minor
  • 45 info

Most severe, free to view

  • Glycerol phenylbutyrateA16AX09severe
  • MethotrexateL01BA01severe
  • BaricitinibL04AA37severe
  • BaricitinibL04AF02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Probenecid in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All probenecid products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Germany · Probenecid Biokanol, Probenecid Weimer
  • Denmark · Probenecid Medic
  • France · Santuril
  • Norway · Probecid
  • Sweden · Probecid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9f471ce-3343-48c6-9711-9cfc137b2c07
GET /v1/drugs/d9f471ce-3343-48c6-9711-9cfc137b2c07?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "probenecidum 500 mg",
  "valid_from": "2023-08-01",
  "limitations": "[{\"description\":\"Zur Behandlung der symptomatischen Hyperurikämie (Gichtarthritis) bei Patienten, die mit anderen die Harnsäure senkenden Arzneimitteln nicht behandelt werden können.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-12-01\"}]",
  "galenic_form": "Tabl 500 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2006-03-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about probenecid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console